Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP809310.RAO5MEwUaidyGOuvrkwUfwieV-8C_TJ0Qax7uZvTMKmwU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP809310.RAO5MEwUaidyGOuvrkwUfwieV-8C_TJ0Qax7uZvTMKmwU130_assertion type Assertion NP809310.RAO5MEwUaidyGOuvrkwUfwieV-8C_TJ0Qax7uZvTMKmwU130_head.
- NP809310.RAO5MEwUaidyGOuvrkwUfwieV-8C_TJ0Qax7uZvTMKmwU130_assertion wasGeneratedBy ECO_0000203 NP809310.RAO5MEwUaidyGOuvrkwUfwieV-8C_TJ0Qax7uZvTMKmwU130_provenance.
- NP809310.RAO5MEwUaidyGOuvrkwUfwieV-8C_TJ0Qax7uZvTMKmwU130_assertion wasDerivedFrom befree-2016 NP809310.RAO5MEwUaidyGOuvrkwUfwieV-8C_TJ0Qax7uZvTMKmwU130_provenance.
- NP809310.RAO5MEwUaidyGOuvrkwUfwieV-8C_TJ0Qax7uZvTMKmwU130_assertion SIO_000772 20430935 NP809310.RAO5MEwUaidyGOuvrkwUfwieV-8C_TJ0Qax7uZvTMKmwU130_provenance.
- NP809310.RAO5MEwUaidyGOuvrkwUfwieV-8C_TJ0Qax7uZvTMKmwU130_assertion evidence source_evidence_literature NP809310.RAO5MEwUaidyGOuvrkwUfwieV-8C_TJ0Qax7uZvTMKmwU130_provenance.
- NP809310.RAO5MEwUaidyGOuvrkwUfwieV-8C_TJ0Qax7uZvTMKmwU130_assertion description "[The clinical features of FXTAS, as well as other forms of clinical involvement in carriers without FXTAS, are thought to arise from a toxic gain of function of transcriptionally active FMR1 containing expanded CGG repeats.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809310.RAO5MEwUaidyGOuvrkwUfwieV-8C_TJ0Qax7uZvTMKmwU130_provenance.